search - Mayo Clinic Laboratories

Web:	mayocliniclabs.com
Email:	mcl@mayo.edu
Telephone:	800-533-1710
International:	+1 855-379-3115
Values are valid only on day of printing

Neurofascin 155 IgG4 Antibody Test [Test in Focus] - Insights

John Mills, Ph.D., explains Mayo Clinic Laboratories' new neurofascin 155 (NF155) IgG4 antibody test, which is the first commercially available test in the U.S. to use flow cytometry to detect for NF155 antibodies and confirm diagnosis of...

Improving outcomes through comprehensive controlled substance monitoring - Insights

Controlled substance testing options vary in the details they provide about patient drug use, painting an incomplete picture of usage patterns that can hinder accurate prescription monitoring and treatment outcomes. However, a new...

High-resolution targeted stimulant and phencyclidine (PCP) screen - Insights

In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted stimulant and PCP screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of...

Then and now: Upholding Mayo Clinic's core values - Insights

Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.

Complex testing offers answers and guidance about a lifelong illness - Insights

For patients with chronic lymphocytic leukemia (CLL) — the most common leukemia in adults — advanced testing can not only provide valuable information about their disease state, but peace of mind in the face of a progressive, incurable...

An inside look at the state-of-the-art supports enabling invention - Insights

A web of innovation within Mayo Clinic Laboratories links research and test development with clinical practice, enabling for some of the world’s most pioneering methodologies. Underpinning this innovation network are unique supports that...

A web of care, close to home: Support on the cancer journey - Insights

Dr. Dollahite received world-class cancer treatment from a web of health care organizations, including Mayo Clinic in Rochester, Minnesota. Yet she never left New York; most of her treatment occurred in Ithaca. What made that possible was...

newborn-screen-elevated-c8-acylcarnitine-lesser-elevations-c6-c10-acylcarnitines.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 08/2023 Newborn screen results: ■ Elevated C8 acylcarnitine ■ Lesser elevations of C6 and C10 acylcarnitines Perform: Glucose, electrolytes, blood gas, liver...

Atria Senior Living: COVID-19 testing protects the most vulnerable - Insights

When most of the world was still struggling to understand how COVID-19 would affect their lives, Atria Senior Living took steps to protect their vulnerable residents and staff.

Shining light on one family's struggle: Barbara, Deborah, Pamela, and Rylie - Insights

Before testing at Mayo Clinic Laboratories, Barbara Domaille, Deborah Neville, Pamela Neville, and Rylie Ronnenberg thought there could be a genetic connection to the hip problems they shared. After the testing, they knew for sure.

Transforming clinical practice and changing outcomes for brain tumor patients - Insights

The genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the...

Testing for a surprising antigen enables insight into a chronic kidney illness - Insights

Mayo Clinic renal pathologist Dr. Sanjeev Sethi identified NELL-1 as a biomarker for membranous nephropathy (MN) in 2019. Two years later, Dr. Sethi helped implement the first ever IHC test to detect NELL-1 antigen, which appears in about...

Thank you to all our staff during the time of COVID-19 - Insights

Thank you to our staff at Mayo Clinic who step up daily during this time of need to provide access to testing during the global pandemic. We appreciate each one of you and all the sacrifices you personally have made throughout this past...

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

The Region 4 Stork (R4S) Collaborative Project - Insights

This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.

The birth of Mayo Clinic Laboratories: From tiny operation to international mainstay - Insights

In 1971, the Regional Laboratory, later to become Mayo Clinic Laboratories, was founded. For the first time in Mayo Clinic’s history, the institution would support the community practice of pathology for outside patients in the region and...

Cayuga Medical Center: Building a world-class lab that drives revenue - Insights

Cayuga Medical Center sought to challenge the narrative that a hospital’s lab is an expensive liability by positioning themselves as the laboratory of choice in their area.

Interpretation of qualitative and quantitative urine opiate tests for pain management patients - Insights

In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the use of qualitative urine screening assays and quantitative confirmatory testing to determine compliance in pain management patients.

Avoid seller's remorse: Why owning your lab makes sense - Insights

For community health care providers, owning a laboratory has been likened to shoveling money down a giant drain. Cayuga Medical Center is challenging that narrative. Instead of selling, Cayuga is investing in its lab — which it considers a...

Rare Lyme disease-causing bacteria spotted on routine blood films - Insights

It’s been understood for some time that an infection of B. mayonii, a rare species of bacterium, results in high levels of spirochetes in the peripheral blood. But actually being able to visualize them on a routine peripheral blood smear...

LinkedIn Login, Sign in | LinkedIn

Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.

Compassionate, knowledgeable death care brings Mayo Clinic's mission full circle - Insights

The Office of Decedent Affairs plays a key role in Mayo Clinic’s mission as its staff guide families through the logistics and complexities of a loved one’s death with skill and empathy.

GeoBioMed: How geologic rock formations inform novel treatments for kidney stones - Part I - Insights

A collaborative study between Mayo Clinic and the University of Illinois debunked the previous consensus about how kidney stones grow.

Mass spectrometry-based assay detects viral antigens directly from clinical specimens - Insights

In a newly published study, a team from Mayo Clinic’s Advanced Diagnostics Laboratory has developed a mass spectrometry-based assay that’s able to detect COVID-19 (SARS-CoV-2) pathogens from human proteins with, remarkably, 98% sensitivity...

Next-generation sequencing: Examining an often oversimplified & misunderstood technology - Part III - Insights

With the rise of next generation sequencing (NGS) technology, multigene panel testing is expanding so rapidly that clinical practice is racing to keep pace. And questions within genetic tests have expanded along with it, making definitive...

LabConnect and Mayo Clinic BioPharma Diagnostics: Driving the future of medicine through clinical trials - Insights

Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-class laboratory testing and resources to industry partners conducting...

GeoBioMed: How geologic rock formations inform novel treatments for kidney stones - Part II - Insights

Part II of this series shows how a breakthrough discovery about how kidney stones form may open the way for new, unorthodox treatments. The discovery was made possible by joining University of Illinois’ geology and biology forces with Mayo...

CPT Codes and LOINC Updates Archives - Page 4 of 6 - Insights